Nephroprotective effect of GSK-3β inhibition by lithium ions and δ-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicity

Toxicology Letters

Volumn 220, Issue 3, 2013, Pages 303-308

  Plotnikov, E Y ^a   Grebenchikov, O A ^b   Babenko, V A ^a   Pevzner, I B ^a   Zorova, L D ^a   Likhvantsev, V V ^b   Zorov, D B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Aminoglycoside; Glycogen synthase kinase; Mitochondria; Reactive oxygen species; Tubular necrosis

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; GENTAMICIN; GLYCOGEN SYNTHASE KINASE 3BETA; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LITHIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY TUBULE CELL; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION;

ACUTE KIDNEY INJURY; ANIMALS; BLOTTING, WESTERN; CATIONS, MONOVALENT; CELL DEATH; ENKEPHALIN, LEUCINE-2-ALANINE; GENTAMICINS; GLYCOGEN SYNTHASE KINASE 3; HISTOCYTOCHEMISTRY; LITHIUM COMPOUNDS; MALE; RANDOM ALLOCATION; RATS; RECEPTORS, OPIOID, DELTA;

EID: 84879836895     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.04.023     Document Type: Article

References (30)

1. Begg E.J., Barclay M.L. Aminoglycosides - 50 years on. British Journal of Clinical Pharmacology 1995, 39:597-603.
2. Blais A., Morvan-Baleynaud J., Friedlander G., Le Grimellec C. Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. Kidney International 1993, 44:13-18.
3. Edson R.S., Terrell C.L. The aminoglycosides. Mayo Clinic Proceedings 1999, 74:519-528.
4. Efrati S., Averbukh M., Berman S., Feldman L., Dishy V., Kachko L., Weissgarten J., Golik A., Averbukh Z. N-acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrology, Dialysis, Transplantation 2005, 20:65-70.
5. El Mouedden M., Laurent G., Mingeot-Leclercq M.P., Taper H.S., Cumps J., Tulkens P.M. Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides. Antimicrobial Agents and Chemotherapy 2000, 44:665-675.
6. Fryer R.M., Hsu A.K., Eells J.T., Nagase H., Gross G.J. Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circulation Research 1999, 84:846-851.
7. Jankauskas S.S., Plotnikov E.Y., Morosanova M.A., Pevzner I.B., Zorova L.D., Skulachev V.P., Zorov D.B. Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycin-induced renal failure and hearing loss. Biochemistry. (Moscow) 2012, 77:666-670.
8. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. Journal of Clinical Investigation 2004, 113:1535-1549.
9. Khoory B.J., Fanos V., Dall'Agnola A., Cataldi L. Aminoglycosides, risk factors and neonatal kidney. Pediatria Medica e Chirurgica 1996, 18:495-499.
10. Kuzin M.I., Shloznikov B.M., Likhvantsev B.V., Karelin A.A., Tverskoi A.L., Sitnikov A.V., Grebenchikov O.A., Andreev A.I. A new method of general anesthesia in pulmonary surgery using dalargin instead of narcotic analgesics. Vestnik Akademii Meditsinskikh Nauk SSSR 1990, 7-11.
11. Lasukova T.V., Maslov L.N., Podoksenov Y.K., Podoksenov A.Y., Platonov A.A., Ovchinnikov M.V., Bespalova Z.h.D. Effect of opiate peptide dalargin and des-Tyr-dalargin on cardiac pump function during ischemia-reperfusion. Bulletin of Experimental Biology and Medicine 2004, 137:27-30.
12. Lopez-Novoa J.M., Quiros Y., Vicente L., Morales A.I., Lopez-Hernandez F.J. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney International 2011, 79:33-45.
13. Mingeot-Leclercq M.P., Tulkens P.M. Aminoglycosides: nephrotoxicity. Antimicrobial Agents and Chemotherapy 1999, 43:1003-1012.
14. Morales A.I., Detaille D., Prieto M., Puente A., Briones E., Arevalo M., Leverve X., Lopez-Novoa J.M., El-Mir M.Y. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney International 2010, 77:861-869.
15. Mukhopadhyay P., Horvath B., Zsengeller Z., Zielonka J., Tanchian G., Holovac E., Kechrid M., Patel V., Stillman I.E., Parikh S.M., Joseph J., Kalyanaraman B., Pacher P. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radical Biology and Medicine 2012, 52:497-506.
16. Naryzhnaya N.V., Maslov L.N., Lishmanov Y.B., Gross G.J. Receptor specificity of the antiarrhythmic effect produced by opioid peptides Dalargin and DADLE during myocardial reperfusion. Bulletin of Experimental Biology and Medicine 2002, 133:336-338.
17. Oliveira J.L., Silva Junior G.B., Abreu K.L., Rocha Nde A., Franco L.F., Araujo S.M., Daher Ede F. Lithium nephrotoxicity. Revista da Associacao Medica Brasileira 2010, 56:600-606.
18. Pilcher H.R. Drug research: the ups and downs of lithium. Nature 2003, 425:118-120.
19. Plotnikov E.Y., Kazachenko A.V., Vyssokikh M.Y., Vasileva A.K., Tcvirkun D.V., Isaev N.K., Kirpatovsky V.I., Zorov D.B. The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney International 2007, 72:1493-1502.
20. Plotnikov E.Y., Vasileva A.K., Arkhangelskaya A.A., Pevzner I.B., Skulachev V.P., Zorov D.B. Interrelations of mitochondrial fragmentation and cell death under ischemia/reoxygenation and UV-irradiation: protective effects of SkQ1, lithium ions and insulin. FEBS Letters 2008, 582:3117-3124.
21. Rougier F., Claude D., Maurin M., Maire P. Aminoglycoside nephrotoxicity. Current Drug Targets Infectious Disorders 2004, 4:153-162.
22. Rybak L.P., Whitworth C.A. Ototoxicity: therapeutic opportunities. Drug Discovery Today 2005, 10:1313-1321.
23. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochemical Journal 1993, 296(Pt 1):15-19.
24. Vasileva A.K., Plotnikov E.Y., Kazachenko A.V., Kirpatovsky V.I., Zorov D.B. Inhibition of GSK-3beta decreases the ischemia-induced death of renal cells. Bulletin of Experimental Biology and Medicine 2010, 149:303-307.
25. Walker P.D., Shah S.V. Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. American Journal of Physiology 1987, 253:C495-C499.
26. Zaitsev S.V., Vinogradov V.A., Sergeeva M.G., Dmitrieva O.F., Ivanikov I.O. Radioimmunologic and radioreceptor studies of the pharmacokinetics of the enkephalin analog dalargin in man. Bulletin of Experimental Biology and Medicine 1986, 101:702-704.
27. Zhivotova E.Y., Fleishman M.Y., Sazonova E.N., Lebed'ko O.A., Timoshin S.S. Gastroprotective effect of dalargin in gastropathy due to treatment with nonsteroid antiinflammatory drugs. Bulletin of Experimental Biology and Medicine 2009, 147:441-443.
28. Zorov D.B. Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria. Kidney International 2010, 77:841-843.
29. Zorov D.B., Filburn C.R., Klotz L.O., Zweier J.L., Sollott S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. Journal of Experimental Medicine 2000, 192:1001-1014.
30. Zorov D.B., Juhaszova M., Yaniv Y., Nuss H.B., Wang S., Sollott S.J. Regulation and pharmacology of the mitochondrial permeability transition pore. Cardiovascular Research 2009, 83:213-225.